Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO‐Pump‐2

AIM: To evaluate the efficacy and safety of ultra rapid lispro (URLi) versus lispro (Humalog(®)) in people with type 1 diabetes on continuous subcutaneous insulin infusion (CSII). MATERIALS AND METHODS: This was a phase 3, 16‐week, treat‐to‐target study in patients randomized to double‐blind URLi (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Warren, Mark, Bode, Bruce, Cho, Jang I., Liu, Rong, Tobian, Janet, Hardy, Thomas, Chigutsa, Farai, Phillip, Moshe, Horowitz, Barry, Ignaut, Debra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251988/
https://www.ncbi.nlm.nih.gov/pubmed/33687783
http://dx.doi.org/10.1111/dom.14368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251988/
https://www.ncbi.nlm.nih.gov/pubmed/33687783
http://dx.doi.org/10.1111/dom.14368

Ejemplares similares